Terms ending in 2035
Every in-force patent on Twist Bioscience Corporation's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,569,822 | De Novo Synthesized Gene Libraries In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 11,559,778 | De Novo Synthesized Gene Libraries In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 11,214,798 | Methods and Compositions for Rapid Nucleic Acid Library Preparation In force · High confidence | Twist Bioscience Corporation | In force | High confidence | |
| US 10,280,417 | Compositions, Methods and Apparatus for Oligonucleotides Synthesis In force · High confidence | Twist Bioscience Corporation | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.